Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.

Buchi, Francesca

Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. [electronic resource] - Leukemia research Jul 2011 - 921-31 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-5835

10.1016/j.leukres.2011.01.033 doi


Acetylation
Apoptosis
Benzamides
Blotting, Western
Cell Proliferation
Drug Resistance, Neoplasm
Electrophoresis, Gel, Two-Dimensional
Fusion Proteins, bcr-abl--genetics
Histone Deacetylase Inhibitors--therapeutic use
Humans
Imatinib Mesylate
Immunoprecipitation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Phosphotyrosine--metabolism
Piperazines--adverse effects
Protein Kinase Inhibitors--adverse effects
Proteome--analysis
Pyrimidines--adverse effects
RNA, Messenger--genetics
Reverse Transcriptase Polymerase Chain Reaction
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Tumor Cells, Cultured
Valproic Acid--therapeutic use